Jacqueline Payton

Medicine & Life Sciences

1. Acute Myeloid Leukemia 100%
2. Mutation 43%
3. Acute Promyelocytic Leukemia 34%
4. B-Lymphocytes 32%
5. Genome 31%
6. Whole Genome Sequencing 31%
7. Epigenomics 30%
8. Genes 26%
9. Neoplasms 25%
10. Synucleins 23%
11. Transcription Factors 22%
12. Myeloid Cells 21%
13. Chromatin 17%
14. DNA Methylation 16%
15. B-Cell Lymphoma 16%
16. Leukemia 15%
17. High-Throughput Nucleotide Sequencing 15%
18. Gene Regulatory Networks 14%
19. Lymphoma 13%
20. Clonal Evolution 13%
21. Gene Expression 13%
22. Long Noncoding RNA 12%
23. Follicular Lymphoma 12%
24. DNA 12%
25. Proteins 10%
26. Recurrence 10%
27. Immunoglobulin Light Chain Genes 10%
28. Oncogene Fusion 10%
29. Methylation 10%
30. B-Lymphoid Precursor Cells 10%
31. Lymphoma, Large B-Cell, Diffuse 9%
32. Proteomics 9%
33. Double-Stranded DNA Breaks 9%
34. hydrogen sulfite 9%
35. Pre-B Cell Receptors 8%
36. Regulator Genes 8%
37. Epigenetic Repression 8%
38. Cytogenetic Analysis 8%
39. Retinoic Acid Receptors 8%
40. Cytogenetics 8%
41. Karyotype 8%
42. T-Lymphocytes 8%
43. Lymphocytes 7%
44. Disease Progression 7%
45. Epigenome 7%
46. Astrocytoma 7%
47. Human respiratory syncytial virus 7%
48. Trisomy 13 Syndrome 7%
49. Histones 7%
50. Alleles 7%